When was Regenosca founded?

Regenosca was founded in 2017 and raised its 1st funding round 2 years after it was founded.

Where is Regenosca located?

Regenosca is headquartered in Lausanne, Switzerland.

Who is the current CEO of Regenosca?

Hans Mattias Larsson of Regenosca.

How many employees does Regenosca have?

As of Aug 31, 2026, the latest employee count at Regenosca is 5.

Is Regenosca a funded company?

Regenosca is a funded company, having raised a total of $1.13M across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Nov 21, 2019.

When was the latest funding round of Regenosca?

Regenosca's latest funding was a $***** Seed round on Jul 26, 2024, with participation from 2 investors.

Where does Regenosca rank among its competitors?

Regenosca ranks 1st amongst 11 active competitors, of which 2 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Regenosca, which secured $1.13M in Jul, 2024.

Who are the top competitors of Regenosca?

Regenosca's top competitors include Impres Medical, Freyja Healthcare and BugSense. Among them, Regenosca secured the most recent funding round in July, 2024.

Regenosca - 2026 Company Profile, Team, Funding & Competitors

Company Details

Regenosca is a developer of implant for bladder tissue reconstruction. The company has developed an implant that is surgically sutured at the site of tissue removal. The bladder is removed where a plastic bag outside the abdomen or the diseased tissue is removed to be replaced by the tissue segment for bladder reconstruction.

Website: www.regenosca.com/
Email ID: *****@regenosca.com

Key Metrics

Founded Year

2017

Location

Lausanne, Switzerland

Stage

Seed

Total Funding

$1.13M in 2 rounds

Latest Funding Round

Seed, Jul 26, 2024, $*****

Investors

Business Angels & 2 more

Ranked

1^st among 11 active competitors

Employee Count

5 as on Aug 31, 2026

Similar Companies

Impres Medical & 11 more

View Regenosca's full profile

Regenosca has raised a total funding of $1.13M over 2 rounds. Its first funding round was on Nov 21, 2019. Its latest funding round was a Seed round on Jul 26, 2024 for $*****. 2 investors participated in its latest round. Regenosca has 3 institutional investors.

Here is the list of recent funding rounds of Regenosca:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 26, 2024	2175273	Seed	9104163	7101248	5003485	1855234
Nov 21, 2019	7589156	Grant (prize money)	3440873	4676849	9578775	Venture Kick

Access funding benchmarks and valuations. Sign up today!

View details of Regenosca's funding rounds and investors

The founders of Regenosca are Eva-Maria Balet and Hans Mattias Larsson. Hans Mattias Larsson is the CEO of Regenosca.

Here are the details of Regenosca's key team members:

Eva-Maria Balet: Co-Founder of Regenosca.
Contact Info: 1 email address
Hans Mattias Larsson: Co-Founder & CEO of Regenosca.
Contact Info: 1 email address

View details of Regenosca's Founder profiles and Board Members

Regenosca's employee count trend

Regenosca has 5 employees as of Aug 26. Here is Regenosca's employee count trend over the years:

Uncover Regenosca's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Regenosca include Impres Medical, Freyja Healthcare and BugSense. Here is the list of Top 10 competitors of Regenosca, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Regenosca 2017, Lausanne (Switzerland), Seed	Developer of implant for bladder tissue reconstruction	$1.13M	MassChallenge, Business Angels & 1 others	33/100
2nd	Impres Medical 1999, Minnetonka (United States), Series C	Provider of minimally invasive products for uterine bleeding	$10.9M	Johnson & Johnson Innovation – JJDC, Wavepoint Ventures ... & 2 others	31/100
3rd	Freyja Healthcare 2016, Boston (United States), Unfunded	Developer of medical device for women health	-	-	29/100
4th	BugSense 2019, Munich (Germany), Unfunded	Developer of diagnostic device for the diagnosis of urinary tract infections	-	-	27/100
5th	Urology Health Store Canada 2013, Markham (Canada), Unfunded	Developer of device for sexual and urological health for women	-	-	24/100
6th	Aegis Women's Health Technologies 2013, Raleigh (United States), Deadpooled	Medical devices to reduce recurrent urinary tract infections in women	-	-	23/100
7th	Personal Med 2003, Redmond (United States), Unfunded	Medical devices restoring control for incontinence and prolapse with caring support	-	-	23/100
8th	Startup By Massachusetts Institute of Technology Alumni 2020, London (United Kingdom), Unfunded	Developer of medical devices to treat catheter-associated urinary tract infections	-	-	22/100
9th	Sulacare 2021, Mo i Rana (Norway), Funding Raised	Developed a device to simplify urinary catheter insertion in female patients	-	CoFounder	21/100
10th	MinaRosa Technologies 2024, Romulus (United States), Unfunded	Developer of wearable light therapy pad for UTI-related pain relief	-	-	16/100